Device And Method for Non-Invasive Neuromodulation

ABSTRACT

One embodiment involves modifying neural transmission patterns between neural structures and/or neural regions in a noninvasive manner. In a related exemplary method, sound waves are directed toward a first targeted neural structure and characteristics of the sound waves are controlled at the first target neural structure with respect to characteristics of sound waves at the second target neural structure. In response, neural transmission patterns modified to produce the intended effect (e.g., long-term potentiation and long-term depression of the neural transmission patterns). In a related embodiment, a transducer produces the sound for stimulating the first neural structure and the second neural structure, and an electronically-based control circuit is used to control characteristics of the sound waves as described above to modify the neural transmission patterns between the first and second neural structures.

RELATED PATENT DOCUMENTS

This is a conversion of U.S. Provisional Patent Application Ser. No.60/984,225, entitled “Device and Method for Non-InvasiveNeuromodulation,” and filed on Oct. 31, 2007, to which benefit isclaimed under 35 U.S.C. § 119.

FIELD OF THE INVENTION

The present invention relates generally to systems and approaches forstimulation of neural circuits and more particularly to facilitatinglong-term potentiation or long-term depression between neural circuits.

BACKGROUND

Long-term potentiation (LTP) involves the process of establishing anassociation between the firing of two cells or groups of cells. Forinstance, Hebb's rule essentially states that if an axon of cell A isnear enough to excite a cell B and repeatedly or persistently takes partin firing cell B, an increase in the strength of the chemical synapsebetween the cells takes place such that A′s efficiency, as one of thecells firing B, is increased. LTP has been shown to last from minutes toseveral months. Conditions for establishing LTP are favorable when apre-synaptic neuron and a post-synaptic neuron are both depolarized in asynchronous manner. An opposite effect, long-term depression (LTD), hasalso been established. LTD is the weakening of a neuronal synapse thatlasts from hours to months. In the cerebellar Purkinje cells, LTDresults from strong synaptic stimulation. By contrast, in thehippocampus, LTD results from persistent weak synaptic stimulation, orwhen a pre-synaptic neuron and a postsynaptic neuron discharge in anasynchronous manner. Since the establishment of Hebb's original rule,additional “Hebb's Rules” have been proposed for the prediction ofself-organization of neuronal systems, and these rules appear to governthe process by which the brain is effectively sculpted over time inorder to master the demands of the environment.

Neurons and other electrically excitable cells (including cardiac cellsand some endocrine cells) have spontaneous firing rates: they dischargeaction potentials at a baseline rate, in the absence of externalstimulation or suppression. This spontaneous firing rate is affected bytemperature. Generally, the warmer an electrically excitable cell, thefaster the spontaneous firing rate, and the colder the cell, the slowerthe firing rate. When cells become extremely warm, such as in a veryhigh fever, they have a high propensity to fire. At extremes, such anincrease in firing rates may manifest as a risk of a febrile seizure.

Neuromodulation is the control of nerve activity, and is usuallyimplemented for the purpose of treating disease. In the strictest sense,neuromodulation may be accomplished with a surgical intervention likecutting an aberrant nerve tract. However, the semi-permanent nature of asurgical procedure leaves little room for later adjustment andoptimization. Likewise, it could be asserted that neuromodulation can beaccomplished with chemical agents or medications. Chemical agents ormedications may be undesirable because, for example, many medicationsare difficult to deliver to specific anatomy, and because the titration(increasing or decreasing the dose of a medication) is a slow andimprecise way to achieve a desired effect on a specific target.Consequently, the term neuromodulation usually implies the use ofenergy-delivering devices.

Several categories of device-based neuromodulation methods are known inthe art. These include electrical neuromodulation, magneticneuromodulation and opto-genetic neuromodulation.

Electrical nerve stimulation is well-established. Examples of electricalapproaches include transcutaneous electrical nerve stimulation (TENS)units, and the surgically implanted electrodes of deep brain stimulation(DBS). TENS units are used to lessen superficial nerve pain within skinand muscle. Because the device is non-invasive and has a low poweroutput, its use involves little risk. However, the efficacy of TENS islimited to nerve distributions very close to the surface. Additionally,TENS has little focusing ability for targeting with close tolerances.Moreover, its therapeutic use shows a fairly small effective treatmentarea. DBS is a useful approach for treating conditions includingParkinson's disease, essential tremor, epilepsy, chronic pain,depression and obsessive-compulsive disorder. In the case of Parkinson'sdisease, a multi-contact electrode may be neurosurgically implanted inthe subthalamic nucleus of a patient. Once connected to a pulsegeneration unit similar to a cardiac pacemaker device, the electrodesmay be electrically pulsed at various rates, effectively driving theactivity of the neurons immediately adjacent to the electrode contacts,using currents of about 3 amps and voltages between 1 and 10.Subsequently, various configurations of electrode pairs or monopolarconfigurations may be empirically tested on the patient for effect andtolerability. At a later time, the circuit configuration or pulseparameters may be changed by the physician in charge, usually withoutthe need to physically disturb the implanted electrode. One disadvantageof DBS is that, by definition, it requires a highly invasive and riskyneurosurgical implantation procedure. If the site of implantation islater deemed suboptimal, or if the device physically fails, more surgeryis required.

Magnetic stimulation involves the discharge of large capacitors into anelectrically conductive coil placed external to a patient's brain orbody. As electrical current runs through the coil, a magnetic field isinduced, which in turn, induces an electric field in nerve membranes andsurrounding fluid. This forces nerves to depolarize with each dischargeof the capacitors in the machine. Magnetic stimulation, when deliveredat rates of 5-20 Hz, tend to be stimulating to nerves that it affects,for some time after the magnetic pulse delivery has stopped. Pulse ratesof less than 1 Hz tend to suppress the activity of affected nerves afterstimulation has ended. Very fast pulse trains (e.g., 50 Hz), punctuatedby absence of pulses 6-9 times per second (“theta rhythm”) also tend tosuppress the activity of affected neurons. Magnetic neuromodulation, inthe form of repetitive transcranial magnetic stimulation, is useful forthe treatment of depression, and likely several other neurological andpsychiatric conditions. The derived effects may last from minutes tomonths after the end of magnetic treatment. One limitation of magneticneuromodulation is the difficulty in achieving tight focus of theeffect, since magnetic fields capable of penetrating to useful depthtend to be large in footprint, as dictated by the Biot-Savart Law.

Opto-genetic neuromodulation is a newly discovered approach which hasthe advantages of being neuron-type specific. Using this approach,light-sensitive ion channels or pumps are genetically transferred to thetargeted neurons of the brain to be stimulated. A flashing light from animplanted device provides a signal to these channels or pumps toactivate. This leads to either neuronal depolarization, or neuronalhyperpolarization, depending upon the nature of the light-sensitivechannel or pump. Opto-genetic approaches lend themselves to bothneuronal up-regulation and down-regulation. Disadvantages include therequirement of implanted hardware, and the need for the geneticmodification of targeted neurons.

Ultrasound is mechanical vibration at frequencies above the range ofhuman hearing, or above 16 kHz. Most medical uses for ultrasound usefrequencies in the range of 1 to 20 MHz. Low to medium intensityultrasound products are widely used by physicians, nurses, physicaltherapists, masseurs and athletic trainers. The most common applicationsare probably wanning stiff, swollen or painful joints or muscles in amanner similar to a hot compress, but with better penetration. Manyultrasound products have been commercially available for years,including consumer-grade massage machines. By design, the power on thesedevices is designed to be too low to warm or otherwise affect structuresmore than two centimeters or so below the surface. Also, these devicesare not capable of tight focus at depth, nor are there means foraccurately aiming such devices toward precise structural coordinateswithin the body. As ultrasound of sufficient strength can cause pain inperipheral nerves with each pulse, it is likely that mechanicalperturbations caused by ultrasound can cause nerves to discharge.

SUMMARY OF THE INVENTION

Various aspects of the present invention are directed to addressing theabove issues and/or generally advancing technology in theabove-discussed contexts and other contexts.

In accordance with one embodiment, the present invention is directed tomethods, devices and systems that are used to modify neural transmissionpatterns between neural structures and/or regions. Consistent herewith,one exemplary method involves directing sound waves toward a firsttargeted neural structure, controlling characteristics of the soundwaves at the first target neural structure with respect tocharacteristics of sound waves at the second target neural structure,and in response, modifying neural transmission patterns. In a relatedembodiment, a transducer produces the sound for stimulating the firstneural structure and the second neural structure, and anelectronically-based control circuit is used to control characteristicsof the sound waves as described above to modify the neural transmissionpatterns between the first and second neural structures.

In accordance with one embodiment, the present invention is directed tomethods, devices and systems that are used to modify neural transmissionpatterns between neural structures and/or regions. Consistent herewith,one exemplary method involves directing stimuli toward a first targetedneural structure, controlling characteristics of the stimulus at thefirst target neural structure with respect to characteristics ofstimulus at the second target neural structure, and in response,modifying neural transmission patterns. In a related embodiment, atransducer produces the stimulus for the first neural structure and thesecond neural structure, and an electronically-based control circuit isused to control characteristics of the stimulus as described above tomodify the neural transmission patterns between the first and secondneural structures.

As discussed with the detailed description that follows, more specificembodiments of the present invention concern various levels of detailfor controlling the neural-transmission modulation.

The above summary of the present invention is not intended to describeeach illustrated embodiment or every implementation of the presentinvention. The figures in the detailed description that follow moreparticularly exemplify these embodiments.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of thedetailed description of various embodiments of the invention thatfollows in connection with the accompanying drawings, in which:

FIG. 1 shows a system for altering neural patterns between two groups ofcells, according to an example embodiment of the present invention;

FIG. 2A shows the use of two focused-beam ultrasound transducersphysiologically suppressing the connection between two regions,according to an example embodiment of the present invention;

FIG. 2B shows the use of an electronically focused ultrasound transducerarray to physiologically augment the connection between two regions,according to an example embodiment of the present invention;

FIG. 3A shows a specific application of the present invention in whichLTP is facilitated within the “trisynaptic circuit” of the humanhippocampus, according to an example embodiment of the presentinvention;

FIG. 3B shows the use of the present invention, to produce LTP betweenthe entorhinal cortex and the CA3 fields of a human hippocampus, as canbe used to augment the encoding of memory, according to an exampleembodiment of the present invention;

FIG. 4A shows the use of two focused-beam ultrasound transducers, eachfocused upon a different, but connected neural target, according to anexample embodiment of the present invention; and

FIG. 4B shows an array of multiple small ultrasound transducers whichmay be electronically directed at one or more target regions within apatient's brain via a coordinated phase and power adjustment, alsoaccording to the present invention.

While the invention is amenable to various modifications and alternativeforms, specifics thereof have been shown by way of example in thedrawings and will be described in detail. It should be understood,however, that the intention is not to limit the invention to theparticular embodiments described. On the contrary, the intention is tocover all modifications, equivalents, and alternatives falling withinthe spirit and scope of the invention.

DETAILED DESCRIPTION

The present invention is believed to be useful for enabling practicalapplication of a variety of LTP and LTD systems, and the invention hasbeen found to be particularly suited for use in systems and methodsdealing with generating LTP or LTD effects in neural circuits throughthe use of sounds waves (which may include high-intensity focusedultrasound), radio frequency (RF) transmissions, electrical current,magnetic fields or ionizing radiation. In the context of this invention,the terms “sound” and “ultrasound” are used interchangeably. Forsimplicity, while the present invention is not necessarily limited tosuch applications, various aspects of the invention may be appreciatedthrough a discussion of various examples using this context.

Various embodiments of the present invention are directed toward the useof ultrasound to produce LTP or LTD within a living subject. Sound wavesare used to stimulate a first portion of neurons. For LTP, the soundwaves are used to concurrently stimulate a second portion of neurons ina synchronous manner. For LTD, the sound waves are used to stimulate asecond portion of neurons in an asynchronous manner. Sound waves providestimulation both in terms of thermal properties and mechanical jarring.While specific embodiments and applications thereof involve sound wavesbeing in the ultrasound frequency range, they need not be so limited.For example, aspects of the present invention can employ frequenciesthat are outside of the ultrasound frequency range.

In accordance with one embodiment, the present invention is directed toa method for modifying neural transmission patterns between neuralstructures. The method involves producing and directing sound waves orRF transmissions toward a first targeted neural structure, controllingcharacteristics of the sound waves or RF transmissions at the firsttarget neural structure with respect to characteristics of sound wavesor RF transmissions at the second target neural structure, and therebymodifying neural transmission patterns. In a related embodiment, atransducer produces the sound for stimulating the first neural structureand the second neural structure, and an electronically-based controlcircuit is used to control characteristics of the sound waves asdescribed above to modify the neural transmission patterns between thefirst and second neural structures. In another related embodiment, a RFtransmitter is used to produce RF transmissions and to focus thetransmissions toward a first target neural structure.

In a more specific embodiment, the present invention uses High-intensityFocused Ultrasound (HIFU) as a powerful ultrasound emitter. Inconnection herewith, ultrasound waves are aimed and focused at atargeted depth geometrically, for example, by using a lens at theemitting end, or by using a curved transducer portion (e.g., a partialsphere). Ultrasound may also be aimed and focused electronically, bycoordinating the phase and intensity of individual transducer elementswithin an array, thereby steering the location of greatest intensity,and even correcting for transmission distortions created, for example byinhomogeneities in the skull. As an ultrasound wave travels throughtissue, the mechanical excitation of the tissue generates heat. Thus,the focal point of a HIFU system may be heated substantially in responseto the ultrasound. Excessive heat may cause cell damage or even celldeath. The threshold for cell death is generally bringing the targetedtissue to 56 degrees Celsius for one second, or 52 degrees Celsius for alonger period of time. Also, tissues held above 43 degrees Celsius formore than an hour or so may have their physiological processes(including cell division) interrupted. Accordingly, to change the firingpatterns of targeted neurons, the temperature can be raised to a moremoderate temperature above the normal 37 degrees Celsius. In anotherexample, the targeted neurons may be raised to 40-42 degrees Celsius forrepeated, brief periods of time, resulting in an increased spontaneousfiring rate, and enabling one step of the LTP/LTD induction process.

For further information on the use of such HIFU, and related systems,reference may be made to various literature including, for example, U.S.Pat. No. 4,616,231, filed on Mar. 26, 1984 to Autrey et al. and entitled“Narrow-band beam steering system,” U.S. Pat. No. 4,865,042, filed onAug. 8, 1986 to Umemura et al. and entitled “Ultrasonic irradiationsystem,” U.S. Pat. No. 5,520,188, filed on Nov. 2, 1994 to Hennige etal. and entitled “Annular array transducer,” U.S. Pat. No. 7,175,596filed on Oct. 29, 2001 to Vitek et al. and entitled “System and methodfor sensing and locating disturbances in an energy path of a focusedultrasound system,” U.S. Pat. No. 6,805,129 filed on Oct. 27, 2000 toPless et al. and entitled “Apparatus and method for ablating tissue,”and U.S. Pat. No. 6,506,154 filed on Nov. 28, 2000 to Ezion et al. andentitled “Systems and methods for controlling a phased array focusedultrasound system,” each of which is fully incorporated herein byreference. An MRI guided approach to beam aiming with improved phaseadjustment focusing techniques incorporates stereotactic capabilitiesinto HIFU. Some of the focused ultrasound systems have showneffectiveness for accurately targeting small lesions within the brain,thermally destroying the targeted tissue, and leaving surrounding tissueunharmed. A few devices allow for the destruction of brain tumors in anon-invasive manner (i.e., through an intact skull).

According to yet another embodiment of the present invention, HIFU isused to stimulate two different areas of the brain. The stimulation ofeach area is coordinated in order to facilitate the development ofeither LTP or LTD between the two different areas of the brain. Forexample, each of the areas can be stimulated in a synchronous fashion toproduce LTP. If the stimulation results in an increased rate ofdepolarization of the neurons, the probability that both areas of thebrain will fire at the same time is likewise increased. Moreover, LTPmay be developed where the stimulation results in one of the areasgenerating action potentials more readily in response to stimulus fromthe other area (e.g., by having a lower depolarization threshold). Inorder to produce LTD, the areas may be stimulated in an asynchronousfashion to produce an increased probability of the different areasfiring independently from one another.

In accordance with the present invention, it has been discovered thatnot all neurons react in the same fashion to temperature variations. Forinstance, some neurons increase their firing rate in response to adecrease in temperature and such a response impacts expected efforts indeveloping LTP or LTD. According to certain embodiments of the presentinvention, temperature data regarding these neuron-regions are used indeveloping LTP or LTD between the areas of the brain. In a particularinstance, an area of the brain containing neurons that increase theirrate of fire due to the stimulation is targeted, and at the same time,another area of the brain containing neurons that decrease their rate offire due to stimulation is also targeted. This may be particularlyuseful for facilitating LTD between the targeted areas.

For further information on the use of RF transmitters to elevatetemperatures of target cells, reference can be made to Kato H., IshidaT. “Present and future status of noninvasive selective deep heatingusing RF in hyperthermia” Med Biol Eng Comput. 1993 Jul.; 31 Suppl:S2-11and to Gelvich E A, Mazokhin V N “Contact flexible microstripapplicators (CFMA) in a range from microwaves up to short waves” IEEETrans Biomed Eng. 2002 Sept.; 49(9):1015-23), which are fullyincorporated herein by reference. For simplicity, much of the discussionis limited to ultrasound energy; however, the invention is not solimited. For instance, it should be apparent that for many applicationsthe use of RF frequency energy could be used in place of ultrasoundenergy. Whether by ultrasound, radio frequency energy, or other stimuli,neural effects of the delivered stimulus may be produced by inducedtemperature alteration, electrical stimulation, or by mechanicalperturbation.

FIG. 1 shows a system for altering neural patterns between two groups ofcells, according to an example embodiment of the present invention.Ultrasound (or RF) source 104 focuses the ultrasound (or RF) 106, 108 atlocations 110 and 114. In some instances, the ultrasound can be focusedat only one of the locations, or at one location at a time (e.g., fordeveloping LTD). Control 102 controls the ultrasound produced byultrasound source 104. In a particular instance, control 102 isresponsive to input from monitor device 116. The stimulation from sound(or RF) 106, 108 can be used to effect (e.g., facilitate or frustratethrough LTP or LTD) a pathway 112 between locations 110 and 114.

Ultrasound source 104 can be implemented using a number of differenttechniques and mechanisms. According to one embodiment, ultrasoundsource 104 is implemented using one single transducer for each oflocation 110 and 114. Such a transducer acts as a lens to focus theultrasound waves at a point in space. The control 104 can modify variousaspects of the transducer including, but not limited to, direction offocus, distance from the target location, strength of the ultrasoundwaves or the frequency of the ultrasound waves. Such aspects allow forprecise aiming of the focal point of the ultrasound waves. This can beparticularly useful for reducing unintended stimulation of cells whileincreasing stimulation at the target location. In some instances, thetransducers can be aimed using piezoelectric devices. Piezoelectricdevices allow for minute movements of the transducers in response toelectrical signals.

According to another embodiment, ultrasound source 104 is implementedusing an array of transducers. In one instance, the array can beimplemented as one or more two-dimensional arrays of transducers. Inanother instance, the array can be implemented using a three-dimensionalarray, such as an array placed upon the skull of a patient. Similar tothe single transducer implementation, the control 104 can modify variousaspects of the transducers. In one instance, the transducers are similarto those used by the single transducer implementation in that theyfunction to focus the ultrasound waves at a point in space. The arrayprovides a summation of the effects from the transducers in order tofurther focus ultrasound waves. In one instance, each transducer can beindividually calibrated so as to focus the ultrasound waves at thedesired location. Control 104 can then alter the phase of eachtransducer such that the ultrasound waves provide constructiveinterference rather than destructive interference so as to increase theeffectiveness of the delivered ultrasound energy. In another instance,the individual transducers of the array of transducers offer littledirectional or focusing effect when used in isolation. Control 104modifies the aspects of the ultrasound waves of the array so as toeffectively focus the ultrasound waves at the target location.

In various embodiments of the invention, control 104 can use monitoringdevice 116 to determine the appropriate aspects for the transducer(s).For instance, monitoring device 116 may be implemented using, forexample, the ExAblate® system (InSightec Ltd. Haifa, Israel). The inputfrom such device provides a determination as to the effectiveness of thecurrent settings of transducer(s).

Although not shown, various embodiments of the invention may also beimplemented using devices or methods to effectively determine the targetlocation. These implementations can be particularly useful for providingimproved accuracy of the ultrasound waves by precisely targeting thedesired location. An example of a possible targeting method and systemincludes the targeting system of the ExAblate ® (InSightec Ltd. Haifa,Israel). Alternatively, the system may be targeted by registering theultrasound probes to a commercially available user-configurable tool or“universal tool” on a neuronavigation system such as the StealthStationby the Surgical Navigation Technologies division of Medtronic, Inc.(Minneapolis, Minn.). Targeting may also be achieved by affixingultrasonic transducers to a stereotactic frame, and moving them intocorrect targeting position via frame-based techniques, such as thoseused for neurosurgery.

The display of the effect at the target may be augmented with aregistration and display of calculated or measured temperature at thetarget site, or a measurement or calculation of neuronal activity at thetarget site. Temperature displays, e.g., obtained from thermaltomography systems, may be derived from measured values or fromprojected/calculated values. Examples of measurements and display ofneuronal activity include multichannel EEG (for example Brain ElectricalActivity Monitoring or BEAM) or mangetoencephalography (MEG).

FIG. 2A shows the use of two focused-beam ultrasound transducersphysiologically suppressing the connection between the two regions byvirtue of a mechanism such as long-term depression (LTD). An ultrasoundtransducer 205 delivers ultrasound energy to neural target 210 viaultrasound vectors 206. Ultrasound transducer 215 also delivers energyto neural target 220 via ultrasound vectors 216. Neural target 220 isconnected to neural target 210 via neuronal tract 225. As target 220 andtarget 210 are stimulated in a slow-pulse rate, asynchronous fashion,long-term depression (LTD) process 226 is initiated within tract 225.The presence of LTD makes tract 225 less excitable than it would beunder normal circumstances. In many instances, such a depressedexcitability level is maintained for a period of weeks. Conversely, LTPmay be induced with these focused-beam transducers by changing to a morerapid, regular and strong pulse pattern.

FIG. 2B shows the use of an electronically focused ultrasound transducerarray to physiologically augment the connection between the two regionsby virtue of a mechanism such as LTP, according to an example embodimentof the present invention. Neural target 265 is connected via neuraltract 270, to neural target 260. Ultrasound transducers 251, 252, 253,254 and 255 contribute to the total energy delivered to both neuraltarget 260 (via dashed lines 257) and to neural target 265 (via solidlines 256), by virtue of electronic focusing techniques. Neural target265 and target 260 are stimulated in a rapid and regular fashion toinitiate an LTP process 275 within tract 270. In a specific example, thetarget areas are regularly pulsed at a rate of 1 Hz or more, or mildlyheated at the same time thereby increasing the neuronal firing rate intract 270. This allows for the creating of LTP, or enduring enhancementof the stimulation, along tract 270. The presence of LTP increases theexcitability level of tract 270 relative to normal circumstances. Incertain instances, such an increased excitability level can bemaintained for a period of weeks. Conversely, LTD may also be producedwith this electronically focused transducer array by changing to aweaker, slow, asynchronous pattern of pulsing.

FIG. 3A shows a specific application of the present invention in whichLTP is facilitated within the “trisynaptic circuit” of the humanhippocampus according to an example embodiment of the present invention.In the trisynaptic circuit, cerebral cortical regions (not shown) haveconnections 310 to entorhinal cortex 315. Entorhinal cortex 315 isconnected to CA3 field 320 via connection 317. CA3 field 320 relayssignals to CA1 field 325, via connection 322. CA1 field 325 relays backto entorhinal cortex 315 via connection 327. Finally, entorhinal cortex315 relays data back to cerebral cortex regions via connections 310.When rapid and strong stimulations are applied to entorhinal cortex 315,long-terra potentiation (318) is established along connection 317between entorhinal cortex 315 and CA3 field 320. Moreover, it isbelieved that the application of stimulation to both entorhinal cortex315 and CA3 field 320 may improve the speed at which the LTP effect iscreated and also improve the length that the LTP effect is sustained.

FIG. 3B shows the use of the present invention, (in a form similar tothat shown in FIG. 2B) to produce LTP between the entorhinal cortex andthe CA3 fields of a human hippocampus, as can be used to augment theencoding of memory. Specifically, entorhinal cortex 375 is connected toCA3 field 380 (same as 315 and 320, respectively, in FIG. 3A).Ultrasound transducers 351, 352, 353 and 354 are arranged around apatient's scalp 360 in order to stimulate both the CA3 field 380 (viadashed lines 366) and the entorhinal cortex 375 (via solid lines 365),by virtue of electronic focusing techniques. By stimulating theentorhinal cortex 375 and CA3 field 380 in a rapid and regular fashion,a LTP process 318 is initiated within connecting tract 317 as shown inFIG. 3A.

FIG. 4A shows the use of two focused-beam ultrasound transducers, eachfocused upon a different, but connected neural target, according to anexample embodiment of the present invention. Transducer 415 and 430 eachfocuses ultrasound waves 420 and 435, respectively, to specific pointswithin the brain 410 of patient 400. More specifically, transducer 415focuses the ultrasound to target point 427 and transducer 430 focusesthe ultrasound at target point 445.

The focus points of the transducers can be controlled by modifyingdirection of the ultrasound waves 420 and 435. For instance, transducershaving different curvatures may be used to provide different depths ofconvergence. Likewise, the transducer's position on the skull anddistance therefrom can be modified to set the convergence point withinthe brain 410. The direction of the ultrasound waves can be modified bycontrolling the angle of the transducers 415 and 430 relative to brain410. This can be accomplished using a variety of approaches. One suchapproach involves setting the angle using a structure that supports thetransducers and allows for adjustment of the angle. The patient's skullcan then be immobilized relative to the structure. Another approachinvolves attaching the transducers directly to the patient's scalp,skull, or by surgically implanting them upon or within the brain itself.The angle may be set accordingly.

FIG. 4B shows the use of an array of multiple small ultrasoundtransducers which may be electronically focused upon one or more targetswithin a patient's brain by virtue of a coordinated phase and poweradjustment to the transducers in the array, according to an exampleembodiment of the present invention. An array of transducers 470 isattached to patient 450 for the purpose of stimulating brain 460.Individual control of the transducers is provided through communicationconnections 480, which are shown as wires in FIG. 4B. Examples ofsuitable communications connections include electrical wires, wirelesstransmissions and optical fibers. In some instances, power is deliveredto transducers 470 through the same (or similar) connections.

According to one embodiment of the invention, the power, frequency andphase of the transducers can be modified to pinpoint the desired targetlocations. The delay from the time that the ultrasound wave is firsttransmitted to the time the ultrasound wave arrives at the targetlocation may vary from transducer to transducer (e.g., due todifferences in the location and orientation of the transducers). Forinstance, the distance and type of tissue can directly affect thepropagation time of the ultrasound wave. A control device can compensatefor differences between the transducers to ensure that the ultrasoundwaves add to the power of the stimulation at the desired location. Insome instances, one or more of the transducers may not provide anyappreciable addition to the amount of stimulation at the targetlocation. In other instances, one or more of the transducers may createundesirable effects, such as stimulation of areas other than the targetlocations. For such instances, the transducer power may be reduced orremoved completely. The ineffectiveness of a few of such transducers maybe offset by increasing the power of the other transducers or byproviding a sufficiently large array of transducers. Other variationsare possible including grouping control of a number of transducerstogether rather than individually controlling each transducer. This maybe particularly useful for reducing the complexity of the communicationsand the complexity of various control parameters.

Once the selected phase, frequency and other constraints are set, thetransducers can be used to stimulate two different target areas in asynchronous or asynchronous manner to produce LTP or LTD, respectively,between the different target areas. The invention need not be limited toonly two target areas. For instance, three or more areas of the brainmay be stimulated for the purposes of facilitating LTP or LTDtherebetween. In another instance, a number of different target areasmay be sequentially stimulated to produce an LTP communication pathwayof related target areas. Similarly, a sequence of different target areasmay be stimulated to disrupt a communication pathway by producing LTDbetween the sequential target areas. Various combinations thereof arealso possible.

In conjunction with a specific embodiment of the present invention, thethermal properties of sound waves are supplemented with electricalimpulses generated by implanted devices that respond to mechanicalmotion produced by the sound waves. For instance a device, implantedsurgically in proximity to a group of neurons that one wishes to affect,electrically stimulates those neurons when in receipt of sound waves.

In one such embodiment, implanted piezoelectric antennas are surgicallyimplanted adjacent to the neural structure that is the target of themodulation. Such antennae produce electrical current via thepiezoelectric effect of an implanted piezoelectric generator, which israpidly moved back and forth by externally applied ultrasound. Theelectric current from the piezoelectric generator serves to stimulateneurons electrically, in response to the externally applied ultrasonicwaves. All other principles of synchrony and asynchrony as they apply tothe induction of LTP and LTD, respectively, still hold under thisparadigm. The implanted ultrasound-to-electrical current conversiondevice serves to enhance the same processes as previously describedherein. For further information regarding implanted piezoelectricantennas, reference may be made to recent publications including, forexample, Wang X, Song J, Liu J, Wang Z L, in Direct-currentNanogenerator Driven By Ultrasonic Waves, Science, 2007, Apr.6-316(5821):102-5, which is fully incorporated herein by reference.

In another embodiment of the present invention, such implantable devicescan be implemented as the primary source of stimulation (e.g., withminimal thermal heating).

The various embodiments described above are provided by way ofillustration only and should not be construed to limit the invention.Based on the above discussion and illustrations, those skilled in theart will readily recognize that various modifications and changes may bemade to the present invention without strictly following the exemplaryembodiments and applications illustrated and described herein. Forinstance, such changes may include variations in the duration andfrequency of the stimulation between target areas. Such modificationsand changes do not depart from the true spirit and scope of the presentinvention, which is set forth in the following claims.

1. A system for modifying neural transmission patterns between a firstneural structure and a second neural structure, the system comprising: atransducer arrangement configured and arranged to produce sound forstimulating the first neural structure and the second neural structure;a control circuit configured and arranged to control of characteristicsof sound waves at the first target neural structure with respect tocharacteristics of sound waves at the second target neural structure formodifying the neural transmission patterns between a first neuralstructure and a second neural structure; and implanted piezoelectricantennas configured to produce an electrical current in response to thesound waves.
 2. The system of claim 1, wherein modifying the neuraltransmission patterns includes one of long-term potentiation andlong-term depression of the neural transmission patterns.
 3. The systemof claim 1, wherein the sound waves at first target neural structuresufficiently raise the temperature of the first target neural structureso as to affect the firing rate of neurons in the first target neuralstructure.
 4. The system of claim 1, wherein the transducer arrangementincludes a plurality of transducers that are each configured andarranged to be controlled by the control circuit.
 5. A method formodifying neural transmission patterns between a first neural structureand a second neural structure, the method comprising: producing soundwaves; directing the sound waves to implanted piezoelectric antennasconfigured to produce an electrical current in response to the soundwaves at a first target neural structure and a second target neuralstructure; and controlling characteristics of sound waves at the firsttarget neural structure with respect to characteristics of sound wavesat the second target neural structure to modify neural transmissionpatterns.
 6. A device for neuromodulation comprising: one or more energyemitters configured and arranged to emit energy that is focused to afocal point; a targeting controller configured and arranged to determinea location in space at which the focal point is desired; and an aimingcontroller configured and arranged to direct the focal point toward thelocation in space to non-destructively alter a pattern of functionalresponsiveness of cells at the location in space for a first time periodto change responsiveness between two groups of cells for a second periodof time that is substantially greater than the first period of time. 7.The device of claim 6, further including a secondary group of one ormore energy emitters, wherein each of the two groups of cells isstimulated by one of the energy emitters.
 8. The device of claim 6,wherein the responsiveness between two groups of cells includes neuralconnectivity.
 9. The device of claim 6, wherein the responsivenessbetween two groups of cells is moderated by long-term potentiation(LTP).
 10. The device of claim 6, wherein the responsiveness between twogroups of cells is moderated by long-term depression (LTD).
 11. Thedevice of claim 6, wherein the energy heats a first group of cells ofthe two groups of cells thereby changing a spontaneous firing rate ofthe first group of cells.
 12. The device of claim 6, wherein thealtering of a pattern of functional responsiveness is due to mechanicalperturbations of a cell from the energy.
 13. The device of claim 6,wherein the energy is focused using one of a lens and a curvedtransducer portion.
 14. The device of claim 6, wherein the energy isfocused by aiming an array of the energy emitters at the focal point.15. A system for modifying neural transmission patterns between a firstneural structure and a second neural structure, the system comprising: atransducer arrangement configured and arranged to wirelessly stimulatethe first neural structure and the second neural structure; a controlcircuit configured and arranged to control of characteristics of thestimulus at the first target neural structure with respect tocharacteristics of sound waves at the second target neural structurethereby modifying the neural transmission patterns between a firstneural structure and a second neural structure; and an implantedpiezoelectric antenna configured to produce an electrical current inresponse to the sound waves.
 16. The system of claim 15 wherein thetransducer arrangement produces ultrasound for stimulating the firstneural structure and the second neural structure.
 17. The system ofclaim 15 wherein the transducer arrangement produces radio frequencyenergy for stimulating the first neural structure and the second neuralstructure.
 18. The system of claim 15 wherein the transducer arrangementproduces a magnetic field for stimulating the first neural structure andthe second neural structure.
 19. The system of claim 15 wherein thetransducer arrangement produces ionizing radiation for stimulating thefirst neural structure and the second neural structure.